dc.contributor | AC Camargo Cancer Center | |
dc.contributor | Federal University of Rio Grande do Sul | |
dc.contributor | Universidade Estadual de Campinas (UNICAMP) | |
dc.contributor | Universidade Estadual Paulista (UNESP) | |
dc.contributor | Universidade de São Paulo (USP) | |
dc.contributor | University Brasil | |
dc.date.accessioned | 2022-04-29T08:35:30Z | |
dc.date.accessioned | 2022-12-20T02:54:49Z | |
dc.date.available | 2022-04-29T08:35:30Z | |
dc.date.available | 2022-12-20T02:54:49Z | |
dc.date.created | 2022-04-29T08:35:30Z | |
dc.date.issued | 2021-01-01 | |
dc.identifier | Oral Surgery. | |
dc.identifier | 1752-248X | |
dc.identifier | 1752-2471 | |
dc.identifier | http://hdl.handle.net/11449/229722 | |
dc.identifier | 10.1111/ors.12675 | |
dc.identifier | 2-s2.0-85117246930 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5409856 | |
dc.description.abstract | Background: Fixed drug eruption is a drug reaction characterized by the recurrent occurrence of erosive or ulcerative lesions in skin or mucosa surfaces upon the use of a specific drug. The occurrence of fixed drug eruption in oral mucosa is rare and ill documented. Case report: A 37-year-old woman who presented with recurrent erosive lesions in the palatal marginal gingiva of the upper first molars for 3 consecutive months. In anamnesis and follow-up, the time association with the intake of piroxicam to treat menstrual pain led us to the diagnosis of fixed drug eruption. Conclusion: Piroxicam is a rare culprit drug to fixed drug eruption, especially in oral mucosa. | |
dc.language | eng | |
dc.relation | Oral Surgery | |
dc.source | Scopus | |
dc.subject | differential diagnosis | |
dc.subject | erosive | |
dc.subject | fixed drug eruption | |
dc.subject | gingival | |
dc.subject | mucosal | |
dc.subject | oral | |
dc.subject | palate | |
dc.title | Piroxicam-induced fixed drug eruption in palatal mucosa | |
dc.type | Artículos de revistas | |